MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03067cam a22004097i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
19042189 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240108120632.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160404s2017 ne b 001 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2016937828 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323399814 |
| Qualifying information |
hardcover |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0323399819 |
| Qualifying information |
hardcover |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocn961248692 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BUL |
| Language of cataloging |
eng |
| Transcribing agency |
BUL |
| Description conventions |
rda |
| Modifying agency |
BUL |
| -- |
BUL |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
lccopycat |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QW 810 M626 2017 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Micro- and nanotechnology in vaccine development / |
| Statement of responsibility, etc. |
edited by Mariusz Skwarczynski, School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, QLD, Australia, Istvan Toth, School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, QLD, Australia, School of Pharmacy, University of Queensland, Woolloongabba, QLD, Australia, Institute for Molecular Biosciences, University of Queensland, St Lucia, QLD, Australia. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Amsterdam ; |
| -- |
Boston : |
| Name of producer, publisher, distributor, manufacturer |
Elsevier/William Andrew, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2017] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xviii, 441 pages |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
25 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Micro & nano technologies series |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Table of Contents<br/>1. The growing influence Nanotechnology in our lives <br/>2. Nanotechnology in medical research <br/>3. Introduction to vaccines and vaccination <br/>4. Overview of the immune systems <br/>5. The role of antigen presentation and innate immunity during immune induction by particular antigens <br/>6. Inflammatory/Noninflammatory adjuvants and nanotechnology the secret t vaccine design <br/>7. Vaccine adjuvant nanotechnologies <br/>8. Nanoparticle-based peptide vaccines <br/>9. Micro particles and Nanoparticles for cancer-targeting vaccines <br/>10. Polymer based Nanoparticles as modern vaccine delivery systems<br/>11. Virus-like particles <br/>12. Liposomes as a vaccine delivery system<br/>13. Nanomaterials based on lipids for vaccine development <br/>14. Microparicles for vaccine delivery <br/>15. Nasal vaccine delivery <br/>16. Towards mucosal DNA delivery. structural modularity in vaccine <br/>17. Nano- and mictrotechnology in skin delivery of vaccines<br/>18. Nanopatches for vaccine delivery <br/>19. Rationale for pulmonary vaccine delivery: formulation and device considerations<br/>20. Nan toxicology and Nan vaccines <br/>21. Regulatory development of Nanotechnology-based vaccines <br/>22 Commercial aspects of vaccines development <br/> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vaccines. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vaccines |
| General subdivision |
Development. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Nanotechnology. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vaccines |
| General subdivision |
pharmacology. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Vaccines. |
| Source of heading or term |
fast |
| Authority record control number or standard number |
(OCoLC)fst01163573 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Skwarczynski, Mariusz, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Tóth, István, |
| Dates associated with a name |
1946- |
| Relator term |
editor. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Micro & nano technologies. |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
copycat |
| d |
2 |
| e |
ncip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book Closed Access |
| Classification part |
QW 810 |
| Item part |
1 |
| Call number prefix |
M626 2017 |
| Call number suffix |
QW 810 M626 2017 |
